Geode Capital Management
ALLR icon

Geode Capital Management’s Allarity Therapeutics ALLR Stock Holding History

Geode Capital Management’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$163K Buy
155,290
+423
+0.3% +$530 ﹤0.01% 3930
2026
Q2 		$200K Sell
154,867
-35,526
-19% -$50.4K ﹤0.01% 3916
2026
Q1 		$208K Buy
190,393
+33,753
+22% +$36.3K ﹤0.01% 3899
2025
Q4 		$169K Buy
156,640
+4,713
+3% +$6.01K ﹤0.01% 3966
2025
Q3 		$240K Buy
151,927
+101,277
+200% +$127K ﹤0.01% 3863
2025
Q2 		$51.2K Buy
50,650
+16,729
+49% +$15.8K ﹤0.01% 4210
2025
Q1 		$31.8K Buy
+33,921
New +$35.1K ﹤0.01% 4273
2024
Q3 		– Sell
-3,411
Closed -$21.8K – 4536
2024
Q2 		$21.8K Buy
+3,411
New +$134K ﹤0.01% 4432
2023
Q1 		– Hold
0
– -$8K – 4804
2022
Q4 		– Hold
0
– – – 4856
2022
Q3 		– Hold
0
– – – 4837
2022
Q2 		– Hold
0
– – – 4828
2022
Q1 		– Hold
0
– – – 4913

Other funds holding ALLR

Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $96.6B AUM 22.52% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Danske Bank
Danske Bank Copenhagen K, Denmark $50.1B AUM 35.17% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $273B AUM 15.34% 1-Year Est. Return

Geode Capital Management's ALLR Position: Q3 2026 in Review

Geode Capital Management increased its Allarity Therapeutics (ALLR) stake by 0.27% in Q3 2026, buying an estimated $530 and bringing the position to 155,290 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #3930.

Geode Capital Management first reported a position in ALLR in Q2 2024 and has held it in 8 quarters since. The position peaked at $240K in Q3 2025. 11 funds tracked by Wall St. Rank hold ALLR as of Q3 2026.

  • Geode Capital Management held 155,290 shares of Allarity Therapeutics worth $163K as of Q3 2026.
  • Geode Capital Management bought 423 Allarity Therapeutics shares in Q3 2026, an estimated $530.
  • Allarity Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3930 holding.
  • Geode Capital Management first reported a position in Allarity Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Geode Capital Management's Allarity Therapeutics position peaked at $240K in Q3 2025.
  • 11 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.